Alerta De Seguridad para Axxess Drug Eluting Coronary Bifurcation Stent System

Según Department of Health, este evento ( alerta de seguridad ) involucró a un dispositivo médico en Hong Kong que fue producido por Biosensors International.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • Fecha
    2013-12-13
  • Fecha de publicación del evento
    2013-12-13
  • País del evento
  • Fuente del evento
    DH
  • URL de la fuente del evento
  • Notas / Alertas
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Notas adicionales en la data
    Medical Device Safety Alert
  • Causa
    Medical device safety alert: biosensors international axxess drug eluting coronary bifurcation stent system medical device manufacturer, biosensors international, has issued a field safety notice concerning 4.0 x 9mm model of axxess drug eluting coronary bifurcation stent system (axbf-4009) (lot numbers: w13090159 and w13080132). several cases with deployment difficulty have been reported to biosensors international group to date, concerning the affected device. physicians in these cases found it either difficult or impossible to pull back the deployment actuator. this could potentially lead to a sub-optimal deployment. in most cases, the stent was successfully deployed, resulting in a positive clinical patient outcome. in the remaining cases, deployment was aborted and patients were administered alternative treatment, with positive patient outcomes. there have been no reports of adverse patient events. the manufacturer has the following recommendations: for all successfully implanted devices, no action is necessary and patients should continue to be managed in accordance with standard patient management protocol. quarantine and return any remaining stocks of affected product. according to the local supplier, the affected products were not distributed in hong kong. if you are in possession of the affected product, please contact your supplier for necessary actions. posted on 13 december 2013.

Device

  • Modelo / Serial
  • Descripción del producto
    Medical Device Safety Alert: Biosensors International Axxess Drug Eluting Coronary Bifurcation Stent System
  • Manufacturer

Manufacturer